粪便钙卫蛋白亚基检测将IBD活动度与肠道炎症慢性化关联
该研究通过尺寸排阻色谱串联质谱分析IBD患者粪便中S100A8和S100A9的蛋白构型,发现活动期IBD粪便中除钙卫蛋白异四聚体外还存在丰富的S100A8和S100A9二聚体。粪便S100A9检测与低钙卫蛋白浓度IBD患者的临床和内镜疾病活动度相关,且S100A8/S100A9同源二聚体可加重小鼠肠道炎症并增强CD4+和CD8+ T细胞活化。
要点
- 活动期IBD粪便中除钙卫蛋白外含丰富S100A8和S100A9二聚体
- 低钙卫蛋白浓度IBD患者中粪便S100A9与疾病活动度相关
- S100A8/S100A9同源二聚体促炎,药物抑制S100A9改善慢性结肠炎
核心结论
- 粪便S100A9二聚体检测与IBD临床及内镜疾病活动度相关,S100A8和S100A9同源二聚体在肠道中具有促炎作用。
研究设计与样本
- 采用尺寸排阻色谱串联质谱分析IBD患者粪便S100A8和S100A9构型。
- 在毒性及遗传小鼠模型及人上皮和T细胞中系统定义S100A8和S100A9同源二聚体功能。
- 报告了IBD粪便S100A8和S100A9的蛋白相互作用网络。
主要发现
- 活动期IBD患者粪便中除钙卫蛋白异四聚体外还含丰富S100A8和S100A9二聚体。
- 粪便S100A9检测与低钙卫蛋白浓度IBD患者的临床和内镜疾病活动度相关。
- 口服人重组S100A8和S100A9同源二聚体(而非钙卫蛋白异四聚体)加重毒性和遗传小鼠模型肠道炎症。
- 人S100A8和S100A9同源二聚体增强CD4+和CD8+ T细胞活化并促进实验性结肠炎。
- S100a9基因失活可预防实验性肠炎和结肠炎,药物抑制S100A9可改善慢性结肠炎。
临床怎么用
- 在低钙卫蛋白浓度的IBD患者中,粪便S100A9检测可能有助于评估临床和内镜疾病活动度。
- S100A8和S100A9同源二聚体及其促炎通路为IBD诊断和治疗提供了新方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Quantification of the human S100A8/S100A9 tetrameric protein complex in stool, referred to as fecal calprotectin, is an extensively validated biomarker supporting the diagnosis and management of gastrointestinal diseases. Here, we studied the quaternary protein structures (termed configuration) of S100A8 and S100A9 and their biological function in inflammatory bowel diseases (IBD). METHODS: We dissected fecal S100A8 and S100A9 configurations in patients with IBD by size-exclusion chromatography coupled with tandem mass spectrometry and systematically defined human S100A8 and S100A9 homodimer functions compared with the calprotectin heterotetramer (CP) in the intestine of mice and in human epithelium and T cells. Moreover, we report a protein interaction network of fecal S100A8 and S100A9 in IBD. RESULTS: Stool from patients with active IBD contained abundant S100A8 and S100A9 dimers besides CP. Fecal S100A9 detection associated with clinical and endoscopic disease activity in IBD patients with low CP concentration. Oral exposure to human recombinant S100A8 and S100A9 homodimers, but not to CP, worsened intestinal inflammation in toxic and genetic mouse models. Functional profiling revealed that human S100A8 and S100A9 homodimers enhanced activation of cluster of differentiation 4+ and 8+ T cells, which promoted experimental colitis. In turn, genetic inactivation of S100a9 protected against experimental enteritis and colitis, and pharmacologic inhibition of S100A9 ameliorated chronic colitis. CONCLUSIONS: Collectively, this study links the detection of fecal S100A9 dimers with clinical and endoscopic disease activity in IBD and identifies inflammatory actions of S100A8 and S100A9 homodimers in the intestine. Our findings pave the way for novel diagnostic and therapeutic approaches in patients with inflammatory diseases of the intestine.
引用
- Jukic A, Hilbe R, Zundel L, et al. Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation. Gastroenterology. 2025. PMID: 41295942. doi:10.1053/j.gastro.2025.08.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。